CDX-1140
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CDX-1140, covering 2024-10-08 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer [Phase 2]